91756 Federal Register / Vol. 89, No. 224 / Wednesday, November 20, 2024 / Notices 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10320 Health Care Reform 

Insurance Web Portal Requirements 45 

CFR Part 159 

Under the PRA (44 U.S.C. 3501– 

3520), Federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires Federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collections 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Health Care 

Reform Insurance Web Portal 

Requirements 45 CFR part 159; Use: In 

accordance with sections 1103 and 

10102 of The Patient Protection and 

Affordability Care Act, Public Law 111– 

148 (2010) (Affordable Care Act) the 

U.S. Department of Health and Human 

Services (HHS) is tasked with 

developing and implementing an 

internet website portal to assist 

consumers with identifying affordable 

and comprehensive health insurance 

coverage options that are available in 

their State. Consistent with minimizing 

burden and providing consistency in 

data collection, the Centers for Medicare 

& Medicaid Services (CMS) updates its 

HealthCare.gov collection requirements 

as regulatory developments occur. There 

have been no developments since the 

last approved collection that require 

changes to the Paperwork Reduction Act 

(PRA) package. Therefore, we are 

submitting this request as an extension 

of the currently approved information 

collection. Form Number: CMS–10320 

(OMB control number 0938–1086); 

Frequency: Occasionally; Affected 

Public: State, Local, and Tribal 

Governments; Number of Respondents: 

814; Number of Responses: 814; Total 

Annual Hours: 50,653. (For questions 

regarding this collection contact 

Kimberlee Heckstall at 410–786–1647.) 

William N. Parham, III, 

Director, Division of Information Collections 

and Regulatory Impacts, Office of Strategic 

Operations and Regulatory Affairs. 

[FR Doc. 2024–27052 Filed 11–19–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for Office of Management 

and Budget (OMB) Review; Sexual 

Risk Avoidance Education Program 

Performance Analysis Study— 

Extension (OMB #0970–0536). 

AGENCY: Office of Planning, Research, 

and Evaluation, Administration for 

Children and Families, U.S. Department 

of Health and Human Services. 

ACTION: Request for public comments. 

SUMMARY: The Office of Planning, 

Research, and Evaluation (OPRE) and 

the Family and Youth Services Bureau 

in the Administration for Children and 

Families (ACF) request an extension 

without changes of a currently approved 

information collection activity as part of 

the Sexual Risk Avoidance Education 

(SRAE) Program Performance Analysis 

Study (PAS). The goal of the study is to 

collect, analyze, and report on 

performance measures data for the 

SRAE program (OMB Control No. 0970– 

0536; expiration date January 31, 2025). 

The purpose of the requested extension 

is to continue the ongoing data 

collection and submission of the 

performance measures by SRAE grant 

recipients. Minor updates were 

identified to incorporate into the OMBapproved versions of instruments. 

DATES: Comments due December 20, 

2024. OMB must make a decision about 

the collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. You can also obtain 

copies of the proposed collection of 

information by emailing 

OPREinfocollection@acf.hhs.gov. 

Identify all requests by the title of the 

information collection. 

SUPPLEMENTARY INFORMATION: 

Description: The purpose of the SRAE 

program is to educate youth on how to 

voluntarily refrain from nonmarital 

sexual activity and prevent other youth 

risk behaviors. Data will continue to be 

used to determine if the SRAE grant 

recipients are meeting performance 

benchmarks related to their program’s 

mission and priorities. 

The SRAE PAS collects performance 

measures data from SRAE grant 

recipients, program providers, and 

participants. The data include 

information on program structure, cost, 

and support for implementation; 

program attendance, reach, and dosage; 

the characteristics of youth involved in 

programming; youth sexual and other 

risky behavior prior to program 

participation; and youth sexual and 

other risky behavior intentions at 

program exit. The performance 

measures help the ACF program office 

and grant recipients to monitor and 

report on progress in implementing 

SRAE programs and inform technical 

assistance. 

Some of the performance measures 

data come from youth participants 

through surveys SRAE grant recipients 

administer at program entry and exit. 

There are separate versions of the entry 

and exit surveys for middle school 

youth, which exclude some of the more 

sensitive items that are included in the 

versions for high school and older 

youth. There is also a shorter version of 

the entry survey for programs 

conducting impact studies, to reduce 

the burden on participants in those 

programs who are likely responding to 

other surveys as part of their impact 

study. Although there was a version of 

the exit survey for programs conducting 

impact studies in the past, it was 

removed through the previous OMB 

request, and youth in these programs 

now complete the same version of the 

exit survey as other youth. 


khammond on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 89, No. 224 / Wednesday, November 20, 2024 / Notices 91757 

ACF is currently working on future 

revisions to this information collection, 

which will be submitted to OMB for 

review and approval in 2025. Notices 

inviting public comment on those 

revisions will accompany that request, 

but comments received in response to 

this notice could also inform those 

revisions. Through this request process 

minor discrepancies were noted 

between the OMB-approved instruments 

and those currently in use. These minor 

errors were fixed in the versions 

included with the request to OMB. 

Respondents: General Departmental 

(GDSRAE), State (SSRAE), and 

Competitive (CSRAE) grant recipients, 

their subrecipients, and program 

participants. 

ANNUAL BURDEN ESTIMATES

Instrument 

Number of 

respondents 

(total over 

request 

period) 

Number of 

responses 

per 

respondent 

(total over 

request 

period) 

Avg. burden 

per response 

(in hours) 

Total/ 

annual burden 

(in hours) 

(1) Participant Entry Survey 

GDSRAE participants ...................................................................................... 126,130 1 0.1333 16,813 

SSRAE participants ......................................................................................... 317,633 1 0.1333 42,340 

CSRAE participants ......................................................................................... 20,136 1 0.1333 2,684 

(2) Participant Exit Survey 

GDSRAE participants ...................................................................................... 100,904 1 0.1667 16,821 

SSRAE participants ......................................................................................... 254,106 1 0.1667 42,360 

CSRAE participants ......................................................................................... 16,109 1 0.1667 2,685 

(3) Performance reporting data entry form: grant recipients 

GDSRAE grant recipients ................................................................................ 119 2 16 3,808 

SSRAE grant recipients ................................................................................... 39 2 16 1,248 

CSRAE grant recipients ................................................................................... 34 2 16 1,088 

(4) Performance reporting data entry form: subrecipients 

GDSRAE subrecipients ................................................................................... 252 2 13 6,552 

SSRAE subrecipients ...................................................................................... 426 2 13 11,076 

CSRAE subrecipients ...................................................................................... 63 2 13 1,638 

Estimated Total Annual Burden 

Hours: 149,113. 

Authority: 42 U.S.C. 1310. 

Mary C. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2024–27053 Filed 11–19–24; 8:45 am] 

BILLING CODE 4184–83–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2024–P–4163] 

Determination That NOXAFIL 

(Posaconazole) Delayed-Release 

Tablets, 100 Grams Was Not 

Withdrawn From Sale for Reasons of 

Safety or Effectiveness; Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice that appeared in the Federal 

Register on October 16, 2024. The 

document announced that NOXAFIL 

(posaconazole) delayed-release tablets, 

100 grams (g), was not withdrawn from 

sale for reasons of safety or 

effectiveness. The document incorrectly 

listed the dosage strength as 100 g. The 

correct strength is 100 milligrams (mg). 

This notice corrects that error. 

FOR FURTHER INFORMATION CONTACT: Awo 

Archampong-Gray, Center for Drug 

Evaluation and Research, Food and 

Drug Administration, 10903 New 

Hampshire Ave., Bldg. 51, Rm. 6243, 

Silver Spring, MD 20993–0002, 301– 

796–0110, Awo.Archampong-Gray@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In FR Doc. 

2024–23811, published in the Federal 

Register of Wednesday, October 16, 

2024 (89 FR 83504), appearing on pages 

83504 and 83505, the following 

corrections are made: 

1. On page 83504, in the second 

column, the title of the document is 

corrected to read ‘‘Determination That 

NOXAFIL (Posaconazole) DelayedRelease Tablets, 100 Milligrams, Was 

Not Withdrawn From Sale for Reasons 

of Safety or Effectiveness.’’ 

2. On page 83504, in the third 

column, in the SUMMARY, in the first 

paragraph, ‘‘NOXAFIL (posaconazole) 

delayed-release tablets, 100 grams (g),’’ 

is corrected to read ‘‘NOXAFIL 

(posaconazole) delayed-release tablets, 

100 milligrams (mg),’’. 

3. On page 83505, in the first and 

second columns, all uses of ‘‘100 g’’ are 

corrected to read ‘‘100 mg’’. 

Dated: November 7, 2024. 

Kimberlee Trzeciak, 

Deputy Commissioner for Policy, Legislation, 

and International Affairs. 

[FR Doc. 2024–27082 Filed 11–19–24; 8:45 am] 

BILLING CODE 4164–01–P 


khammond on DSK9W7S144PROD with NOTICES